Gilead Sciences, Inc. logo GILD - Gilead Sciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 35
HOLD 21
SELL 1
STRONG
SELL 0
| PRICE TARGET: $135.08 DETAILS
HIGH: $150.00
LOW: $105.00
MEDIAN: $135.00
CONSENSUS: $135.08
UPSIDE: 8.14%

Profitability Ratios

Ratio Value
GP Margin 78.3%
EBIT Margin 5.8%
EBITDA Margin 15.4%
Operating Margin 5.8%
Pretax Margin 2.4%
Cont. Ops Margin 1.7%
Net Margin 1.7%
Bottom Line Margin 1.7%

Liquidity Ratios

Ratio Value
Current Ratio 1.60
Quick Ratio 1.45
Solvency Ratio 0.082
Cash Ratio 0.83

Valuation Ratios

Ratio Value
Price/Earnings 239.97
PEG Ratio -2.62
Forward PEG -2.62
Price/Book 5.96
Price/Sales 4.01
Price/FCF 11.18
Price/Op Cash Flow 10.64

Debt Ratios

Ratio Value
Debt/Assets 0.4528
Debt/Equity 1.3818
Debt/Capital 0.5802
Long-Term Debt/Capital 0.5629
Financial Leverage 3.05

Cash Flow Ratios

Ratio Value
Working Capital Turnover 4.80
Operating Cash Flow Ratio 0.902
Operating Cash Flow/Sales 37.7%
Free Cash Flow/Operating Cash Flow 95.2%

Coverage Ratios

Ratio Value
Debt Service Coverage 1.51
Interest Coverage 1.7011
Short-Term Operating Cash Flow Coverage 5.97
Operating Cash Flow Coverage 0.41
Capital Expenditure Coverage 20.70
Dividend + Capital Expenditure Coverage 2.44

Dividend Ratios

Ratio Value
Payout Ratio 816.2500%
Dividend Yield 3.4015%
Dividend Yield % 3.4015%
Dividend Per Share 3.1419

Per Share Ratios

Ratio Value
Revenue/Share 23.06
EPS 0.385
Debt/Share 22.2037
Cash/Share 9.28
Book Value/Share 15.43
Tangible BV/Share -7.23
Equity/Share 15.50
Operating Cash Flow/Share 8.683
Capital Expenditure/Share 0.419
FCF/Share 8.264

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.696
Earnings Before Tax/EBIT 0.415
Price/Fair Value 5.96
Debt/Market Cap 0.2319
Effective Tax Rate 30.6%
Enterprise Value Multiple 29.75